These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 8104068)

  • 1. Scanning electron microscopy of multidrug resistant cells in haematological and mammary malignancies.
    Galimberti S; Bianchi F; Bernardini N; Mattii L; Dolfi A; Lupetti M; Petrini M
    Cell Mol Biol (Noisy-le-grand); 1993 Jul; 39(5):543-51. PubMed ID: 8104068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic and molecular characterization of tumors in nude mice derived from a multidrug-resistant human leukemia cell line.
    Hill AB; Beck WT; Trent JM
    Cancer Res; 1988 Jan; 48(2):393-8. PubMed ID: 2891436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological, molecular, and cytogenetic analysis of "atypical" multidrug-resistant human leukemic cells.
    Beck WT; Cirtain MC; Danks MK; Felsted RL; Safa AR; Wolverton JS; Suttle DP; Trent JM
    Cancer Res; 1987 Oct; 47(20):5455-60. PubMed ID: 2888532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and biochemical characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell lines.
    Ford JM; Bruggemann EP; Pastan I; Gottesman MM; Hait WN
    Cancer Res; 1990 Mar; 50(6):1748-56. PubMed ID: 1968358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro multidrug resistance of P388 murine leukemia selected for resistance to diaziquone.
    Gutierrez PL; Wilder PJ; Biswal N
    Cancer Commun; 1989; 1(3):181-90. PubMed ID: 2576972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentose phosphate pathway alterations in multi-drug resistant leukemic T-cells: 31P NMR and enzymatic studies.
    Ferretti A; Chen LL; Di Vito M; Barca S; Tombesi M; Cianfriglia M; Bozzi A; Strom R; Podo F
    Anticancer Res; 1993; 13(4):867-72. PubMed ID: 8102518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medroxyprogesterone-acetate reverses the MDR phenotype of the CG5-doxorubicin resistant human breast cancer cell line.
    Zibera C; Gibelli N; Maestri L; Della Cuna GR
    Anticancer Res; 1995; 15(3):745-9. PubMed ID: 7645952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of flow cytometry for multidrug resistance detection in low resistance K562 cells using daunorubicin and monoclonal antibodies.
    Van Acker KL; Van Hove LM; Boogaerts MA
    Cytometry; 1993 Oct; 14(7):736-46. PubMed ID: 7902231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of P388/VMDRC.04, a simple, sensitive model for studying P-glycoprotein antagonists.
    Yang JM; Goldenberg S; Gottesman MM; Hait WN
    Cancer Res; 1994 Feb; 54(3):730-7. PubMed ID: 7905786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and serial quantification of intrahepatic xenografts of human hepatocellular carcinoma in severe combined immunodeficiency mice, and development of therapeutic strategies to overcome multidrug resistance.
    Leveille-Webster CR; Arias IA
    Clin Cancer Res; 1996 Apr; 2(4):695-706. PubMed ID: 9816220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of monoclonal antibodies recognizing a Mr 180,000 P-glycoprotein: differential expression of the Mr 180,000 and Mr 170,000 P-glycoproteins in multidrug-resistant human tumor cells.
    Meyers MB; Rittmann-Grauer L; O'Brien JP; Safa AR
    Cancer Res; 1989 Jun; 49(12):3209-14. PubMed ID: 2566379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistance of murine leukemia cells characterization and correlation with cytochrome P-450 dependent activities, cytosolic calcium and cell cycle state.
    Pfeil D; Bergmann J; Fichtner I; Stein U; Hentschel M; Rothe I; Goan SR
    Anticancer Res; 1994; 14(2A):571-6. PubMed ID: 7912495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution.
    Baldini N; Scotlandi K; Serra M; Shikita T; Zini N; Ognibene A; Santi S; Ferracini R; Maraldi NM
    Eur J Cell Biol; 1995 Nov; 68(3):226-39. PubMed ID: 8603675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a P-glycoprotein-related protein (mini-P-glycoprotein) which is overexpressed in multidrug resistant cells.
    Kawai K; Kusano I; Ido M; Sakurai M; Shiraishi T; Yatani R
    Biochem Biophys Res Commun; 1994 Jan; 198(2):804-10. PubMed ID: 7905266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and characterization of multidrug-resistant human osteosarcoma cell lines.
    Serra M; Scotlandi K; Manara MC; Maurici D; Lollini PL; De Giovanni C; Toffoli G; Baldini N
    Anticancer Res; 1993; 13(2):323-9. PubMed ID: 8100126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved flow-cytometric detection of low P-glycoprotein expression in leukaemic blasts by histogram subtraction analysis.
    Müller MR; Lennartz K; Nowrousian MR; Dux R; Tsuruo T; Rajewsky MF; Seeber S
    Cytometry; 1994 Jan; 15(1):64-72. PubMed ID: 7512893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of soluble P-glycoprotein in culture media and extracellular fluids.
    Chu TM; Lin TH; Kawinski E
    Biochem Biophys Res Commun; 1994 Aug; 203(1):506-12. PubMed ID: 7915520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biological effects of PEMF (pulsing electromagnetic field): an attempt to modify cell resistance to anticancer agents.
    Pasquinelli P; Petrini M; Mattii L; Galimberti S; Saviozzi M; Malvaldi G
    J Environ Pathol Toxicol Oncol; 1993; 12(4):193-7. PubMed ID: 8189374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrastructural changes related to multidrug resistance in CEM cells: role of cytoplasmic vesicles in drug exclusion.
    Bobichon H; Colin M; Depierreux C; Liautaud-Roger F; Jardillier JC
    J Exp Ther Oncol; 1996 Jan; 1(1):49-61. PubMed ID: 9414388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mr 85,000 membrane protein specifically expressed in adriamycin-resistant human tumor cells.
    Hamada H; Okochi E; Watanabe M; Oh-hara T; Sugimoto Y; Kawabata H; Tsuruo T
    Cancer Res; 1988 Dec; 48(24 Pt 1):7082-7. PubMed ID: 2903793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.